This may suggest a transient elevation of these serum cytokine levels, particularly IL-4, over cycles of infection-treatment to reduction at the third cycle as the host apparently gains more regulation and the ability to oppose reinfection, most likely aided by parasite-specific antibody levels that are gradually elevated (from naïve mice to mice undergoing third cycle of infection-treatment). The gene discussed is IL4; the disease is infection.